Drug Trial Radar · NCT07884175
A Study of Updated mRNA Seasonal Influenza Vaccines
Last checked: Nov 20, 2026Latest source record: Nov 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
200
Planned (sponsor's estimate)
Start
Oct 15, 2026
Primary completion
Dec 7, 2026
Study completion Dec 7, 2026
Sponsor
- Lead sponsor
- ModernaTX, Inc.Moderna (MRNA)
- Sponsor type
- Industry
- First posted
- Oct 20, 2026
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, investigator, outcomes assessor)
- Primary purpose
- Prevention
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 65 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the immunogenicity and safety of updated strain-containing compositions of the mRNA-1010 vaccines within the current epidemiological environment.
Conditions
- Seasonal Influenza
Interventions
mRNA-1010Biological
Sterile liquid for injection
Licensed High-Dose Seasonal Influenza VaccineBiological
Sterile liquid for injection
Primary outcomes
What the sponsor says the trial is designed to measure.
- Geometric Mean Titer (GMT) of Anti-Hemagglutinin (HA) Antibodies at Day 29, as Measured by Hemagglutination Inhibition (HAI) AssayTime frame: Day 29
- Number of Participants Reaching Seroconversion at Day 29 as Measured by HAI AssayTime frame: Day 29
- Number of Participants with an HAI Titer ≥1:40 at Day 29Time frame: Day 29
- Geometric Mean Fold Rise (GMFR), as Measured by HAI AssayTime frame: Baseline to Day 29
Locations
4 sites in 1 country. Site status is shown where the registry gives one.
Arizona Clinical Trials
Tucson, Arizona · Recruiting
Johnson County Clin-Trials LLC (JCCT)
Lenexa, Kansas · Recruiting
DelRicht Research at Derby City Direct Primary Care
Louisville, Kentucky · Recruiting
DelRicht Research at Amy Roberts MD and Associates
Town and Country, Missouri · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.